TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Main Feed
Today's Market Intel
Stock Reports
AI Research Reports
Top Stocks
AI-Curated Stock Lists
Commentary
Opinionated Stock Takes
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
IPO Calendar
Upcoming Listings
CommunityDashboard
Log inCreate Account
← Back to TickerSpark
▌Earnings Flash·July 23, 2026

Thermo Fisher Scientific Inc. (TMO) climbs on earnings beats

Thermo Fisher Scientific Inc. (TMO) climbs 10.1% after reporting earnings beats, lifting investor sentiment as the company tops expectations and signals stronger-than-expected performance.

Earnings FlashTMOHealthcareMedical - Diagnostics & Research
By TickerSpark·July 23, 2026·2 min read
Thermo Fisher Scientific Inc. (TMO) climbs on earnings beats
▌Key Takeaway
Thermo Fisher Scientific Inc. (TMO) delivered a clean earnings beat, posting EPS of $6.03 on revenue of $11.99 billion versus estimates of $5.72 and $11.71 billion. The stock surged 10.10% to $579.66, signaling that investors viewed the quarter as a meaningful confirmation of strong execution and continued demand resilience.

Thermo Fisher Scientific Inc. (TMO) beat on both profit and revenue, posting EPS of $6.03 on $11.99B in sales versus $5.72 and $11.71B expected, and the stock climbed 10.10% to $579.66 in regular-session trading.

Key Numbers

  • EPS: $6.03 vs $5.72 estimate, a beat.
  • Revenue: $11.99B vs $11.71B estimate, a beat.
  • Stock reaction: TMO rose 10.10% to $579.66 in regular-session trading.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

  • Day range: shares traded between $570.40 and $587.49.
  • Volume: 2,730,420 shares versus average volume of 2,301,432.

    • A clean beat keeps Thermo Fisher on track

    This was a straightforward strong quarter. Thermo Fisher cleared both top- and bottom-line estimates, and the 10.10% jump in the stock shows investors treated the results as more than a routine beat. For a company with a $215.4B market cap, that is a sharp move.

    The result also fits the company’s recent pattern. Thermo Fisher has now beaten EPS estimates in each of the last five reported quarters, including $5.44 vs $5.25 in April, $6.57 vs $6.45 in January, $5.79 vs $5.50 in October, and $5.36 vs $5.23 a year ago. In plain English, the business keeps clearing the bar, and this quarter did it with a revenue beat as well.

    The market’s message was simple: investors wanted proof that Thermo Fisher could still deliver steady execution, and this quarter gave them that. Higher-than-average volume adds weight to the move rather than making it look like a thin-trading fluke.

    Bottom Line

    TMO earnings came in better than expected across the board, and the stock’s 10.10% regular-session climb says investors see Thermo Fisher Scientific Inc. earnings results as a meaningful positive.

    Read the full TMO research report
    ▌Common Questions

    Frequently asked questions

    +Why did Thermo Fisher Scientific stock rise today?
    Thermo Fisher Scientific Inc. (TMO) rose 10.10% after reporting earnings that beat both profit and revenue expectations. The company posted EPS of $6.03 versus $5.72 expected and revenue of $11.99 billion versus $11.71 billion expected.
    +Did Thermo Fisher beat earnings estimates this quarter?
    Yes. Thermo Fisher Scientific Inc. (TMO) reported EPS of $6.03, above the $5.72 analyst estimate, and revenue of $11.99 billion, above the $11.71 billion consensus. This was a broad-based beat on both the top and bottom lines.
    +How much did TMO stock move after earnings?
    Thermo Fisher Scientific Inc. (TMO) climbed 10.10% in regular-session trading to $579.66. Shares traded between $570.40 and $587.49 on volume of 2,730,420, above the average volume of 2,301,432.
    +Is Thermo Fisher showing a pattern of beating estimates?
    Yes. Thermo Fisher Scientific Inc. (TMO) has now beaten EPS estimates in each of the last five reported quarters. The latest quarter also included a revenue beat, reinforcing the company’s recent pattern of consistent execution.
    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌The Full Report

    Want the full picture on TMO?

    The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

    Read the TMO report →Get Full Access →

    Not ready to subscribe? ·

    ▌The Full Report

    Get the full TMO research report

    • Analyst-grade deep dive
    • Charts, valuation, grades
    • Buy/sell price targets
    Read the TMO report →
    ▌For Active Investors

    Smarter research, on every ticker

    • Daily market intelligence
    • On-demand stock analysis
    • AI analyst chat
    Get Full Access →

    Cancel anytime

    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, free in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌More on TMO

    More to read

    All articles
    Thermo Fisher Scientific Inc. (TMO) rises on deep earnings beat
    TMO

    Thermo Fisher Scientific Inc. (TMO) rises on deep earnings beat

    Thermo Fisher Scientific Inc. (TMO) rises after a broad Q2 beat, margin expansion, and a full-year guidance raise. This deep-dive examines the company’s share-gain narrative, end-market strength, five-quarter EPS beat streak, and what the stronger organic growth outlook could mean for the stock.

    Jul 23·9 min
    Thermo Fisher Scientific Inc. (TMO) rises 9.6% on Q2 beat
    TMO

    Thermo Fisher Scientific Inc. (TMO) rises 9.6% on Q2 beat

    Thermo Fisher Scientific Inc. (TMO) rises sharply after a strong second-quarter earnings report topped Wall Street expectations on both profit and revenue. The healthcare tools giant also posted solid organic growth, signaling firmer demand and prompting investors to reprice the stock higher.

    Jul 23·6 min
    Thermo Fisher Scientific (TMO): Buy on Pullbacks
    TMO

    Thermo Fisher Scientific (TMO): Buy on Pullbacks

    Thermo Fisher remains a scaled, resilient life sciences compounder with strong cash generation and raised 2026 guidance. The stock looks attractive on quality, but valuation and leverage argue for patience rather than chasing it higher.

    Jul 23·19 min